| Title: |
Total Psoas Area and Total Muscular Parietal Area Affect Long-Term Survival of Patients Undergoing Pneumonectomy for Non-Small Cell Lung Cancer |
| Authors: |
Daffrè, Elisa; Prieto, Mathilde; Martini, Katharina; Hoang-Thi, Trieu-Nghi; Halm, Nara; Dermine, Hervè; Bobbio, Antonio; Chassagnon, Guillaume; Revel, Marie Pierre; Alifano, Marco |
| Source: |
Daffrè, Elisa; Prieto, Mathilde; Martini, Katharina; Hoang-Thi, Trieu-Nghi; Halm, Nara; Dermine, Hervè; Bobbio, Antonio; Chassagnon, Guillaume; Revel, Marie Pierre; Alifano, Marco (2021). Total Psoas Area and Total Muscular Parietal Area Affect Long-Term Survival of Patients Undergoing Pneumonectomy for Non-Small Cell Lung Cancer. Cancers, 13(8):1888. |
| Publisher Information: |
MDPI Publishing |
| Publication Year: |
2021 |
| Collection: |
University of Zurich (UZH): ZORA (Zurich Open Repository and Archive |
| Subject Terms: |
Clinic for Diagnostic and Interventional Radiology; 610 Medicine & health |
| Description: |
There is no standardization in methods to assess sarcopenia; in particular the prognostic significance of muscular fatty infiltration in lung cancer patients undergoing surgery has not been evaluated so far. We thus performed several computed tomography (CT)-based morphometric measurements of sarcopenia in 238 consecutive non-small cell lung-cancer patients undergoing pneumonectomy from 1 January 2007 to 31 December 2015. Sarcopenia was assessed by the following CT-based parameters: cross-sectional total psoas area (TPA), cross-sectional total muscle area (TMA), and total parietal muscle area (TPMA), defined as TMA without TPA. Measures were performed at the level of the third lumbar vertebra and were obtained for the entire muscle surface, as well as by excluding fatty infiltration based on CT attenuation. Findings were stratified for gender, and a threshold of the 33rd percentile was set to define sarcopenia. Furthermore, we assessed the possibility of being sarcopenic at both the TPA and TPMA level, or not, by taking into account of not fatty infiltration. Five-year survival was 39.1% for the whole population. Lower TPA, TMA, and TPA were associated with lower survival at univariate analysis; taking into account muscular fatty infiltration did not result in more powerful discrimination. Being sarcopenic at both psoas and parietal muscle level had the optimum discriminating power. At the multivariable analysis, being sarcopenic at both psoas and parietal muscles (considering the whole muscle areas, including muscular fat), male sex, increasing age, and tumor stage, as well as Charlson Comorbidity Index (CCI), were independently associated with worse long-term outcomes. We conclude that sarcopenia is a powerful negative prognostic factor in patients with lung cancer treated by pneumonectomy. |
| Document Type: |
article in journal/newspaper |
| File Description: |
application/pdf |
| Language: |
English |
| ISSN: |
2072-6694 |
| Relation: |
https://www.zora.uzh.ch/id/eprint/208899/1/cancers-13-01888-v2.pdf; info:pmid/33920022; urn:issn:2072-6694 |
| DOI: |
10.3390/cancers13081888 |
| Availability: |
https://www.zora.uzh.ch/id/eprint/208899/; https://doi.org/10.3390/cancers13081888 |
| Rights: |
info:eu-repo/semantics/openAccess ; Creative Commons: Attribution 4.0 International (CC BY 4.0) ; http://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.1FF4BC00 |
| Database: |
BASE |